首页|基于网络药理学探讨藿朴夏苓汤治疗慢性萎缩性胃炎-原发性肝癌异病同治机理

基于网络药理学探讨藿朴夏苓汤治疗慢性萎缩性胃炎-原发性肝癌异病同治机理

扫码查看
藿朴夏苓汤出自《医原》,能宣通气机,清热利湿,本应用于夏热暑湿,因其用药温平,体质虚弱者亦可耐受,历年来,各位医者广泛应用于湿热因素的各类疾病,尤其是治疗慢性萎缩性胃炎(Chronic Atrophic Gastritis,CAG),因其是发病缓慢,迁延难愈的癌前病变,故有较高的治疗价值.另外,原发性肝癌(Primary Liver Cancer,PLC)失代偿期出现的腹水、呕吐、黄疸等消化系统症状也切合本方主治范围.异病同治理论是指拥有相同病机的不同疾病,都可以用同一种方法治疗,方随证立,证型相同,自然可以用同一个方剂治疗.因此,本研究通过网络药理学和分子对接探讨藿朴夏苓汤治疗CAG和PLC的机制异同,预测了藿朴夏苓汤治疗CAG和PLC的作用机制,发现藿朴夏苓汤可能通过调控丝氨酸/苏氨酸蛋白激酶 1(Akt Serine/Threonine Kinase 1,AKT1)、肿瘤蛋白p53(Tumor Protein p53,TP53)、白细胞介素(Interleukin,IL)-6、肿瘤坏死因子(Tumor Necrosis Factor,TNF)、IL-1B、前列腺素氧化环化酶 2(Prostaglandin-Endoperoxide Synthase 2,PTGS2)起到治疗作用,提示藿朴夏苓汤治疗CAG和PLC的共同作用机制可能是促进细胞凋亡,抑制炎症,提高免疫,都涉及到癌症,IL-17信号通路,TNF信号通路等,为进一步实验验证指明方向,体现异病同治的科学性,为深度挖掘传统医学经典方剂在临床上的潜力提供动力,验证异病同治理论在现代临床思维中的科学性.
Discussion on the mechanism of the Huopo Xialing decoction in the treatment of chronic atrophic gastritis and primary liver cancer based on network pharmacology
The Huopo Xialing decoction(藿朴夏苓汤)is from Yiyuan(《医原》),which can promote the ventilator,clear away heat and dampness,over the years,doctors have been widely used in various diseases of damp heat factors,especially chronic atrophic gastritis(CAG),which has a slow onset and prolonged precancerous lesions that are difficult to heal,and has high therapeutic value.In addition,digestive symptoms such as ascites,vomiting,and jaundice in the decompensated stage of primary liver cancer(PLC)are also suitable for the scope of this prescription.The theory of different diseases and the same treatment refers to the fact that different diseases with the same pathogenesis can be treated with the same method,and the formula can be established according to the syndrome,and the same syndrome type can be treated with the same formula.Therefore,this study explored the similarities and differences between the mechanism of the Huopo Xialing decoction in the treatment of CAG and PLC through network pharmacology and molecular docking,predicted the mechanism of action of the Huopo Xialing decoction in the treatment of CAG and PLC,and found that the Huopo Xialing decoction may play a therapeutic role by regulating AKT1,TP53,IL-6,TNF,IL-1B and PTGS2,suggesting that the common mechanism of action of the Huopo Xialing decoction in the treatment of CAG and PLC may be to promote apoptosis,inhibit inflammation and improve immunity,all of which involve cancer.IL-17 signaling pathway,TNF signaling pathway,etc.,point out the direction for further experimental verification,reflect the scientificity of different diseases and treatment,provide impetus for in-depth exploration of the clinical potential of TCM classic formulas,and verify the scientificity of the theory of different diseases and same treatment in modern clinical thinking.

Network pharmacologyChronic atrophic gastritisPrimary liver cancerThe Huopo Xialing decoctionThe theory of different diseases and the same treatment

周一婷、卢雨蓓、李小燕、董洪克

展开 >

甘肃省中医药大学,甘肃 兰州,730000

甘肃省中医院,甘肃 兰州,730000

网络药理学 慢性萎缩性胃炎 原发性肝癌 藿朴夏苓汤 异病同治

2024

中医临床研究
中华中医药学会

中医临床研究

影响因子:0.839
ISSN:1674-7860
年,卷(期):2024.16(1)
  • 18